For example, mutations in the promoter of the telomerase reverse transcriptase (TERT) gene have been identified as pan-cancer driver mutations that function by creation of a de novo transcription factor binding site upstream of TERT, resulting in TERT mRNA upregulation [14, 15]. The gene discussed is TERT; the disease is cancer.